Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40007849
Localisation
Taiwan, Province of China
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
28/11/2024
Statut
Classification
1.5°C
Année cible
2034
Statut
Targets set
Classification
1.5°C
Année cible
2050
Overall Net-Zero Target: Grape King Bio Ltd. commits to reach net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: Grape King Bio Ltd. commits to reduce absolute scope 1 and 2 GHG emissions 58.8% by 2034 from a 2023 base year. Grape King Bio Ltd. also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, fuel- and energy-related activities, upstream transportation and distribution, downstream transportation and distribution and end-of-life treatment of sold products 35.0% within the same timeframe. Long-Term Targets: Grape King Bio Ltd. commits to reduce absolute scope 1 and 2 GHG emissions 90.0% by 2050 from a 2023 base year. Grape King Bio Ltd. also commits to reduce absolute scope 3 GHG emissions 90.0% within the same timeframe.
Statut
Targets setAnnée cible
2050
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
TW0001707008
Source : Science Based Targets initiative | Données publiques